(주)엔테라퓨틱스

{
  "address": "서울특별시 관악구",
  "ceo_name": "강재승",
  "certificate": [
    {
      "cert_number": "20210300205",
      "changes": "",
      "disclosure_date": "2021-02-10",
      "first_cert_date": "2021-02-10",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2021-02-10 ~ 2023-02-09"
    },
    {
      "cert_number": "20230104010006",
      "changes": "",
      "disclosure_date": "2023-01-04",
      "first_cert_date": "2021-02-10",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2023-02-10 ~ 2026-02-09"
    },
    {
      "cert_number": "20260113010022",
      "changes": "소재지",
      "disclosure_date": "2026-01-13",
      "first_cert_date": "2021-02-10",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2026-02-10 ~ 2029-02-09"
    }
  ],
  "company_name": "(주)엔테라퓨틱스",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 221042000,
      "cost_of_sales": 0,
      "current_assets": 202332000,
      "current_liabilities": 172726000,
      "gross_profit": 0,
      "net_income": -1146112000,
      "net_income_bs": -1146112000,
      "non_current_assets": 63526000,
      "non_current_liabilities": 12052000,
      "non_operating_expenses": 0,
      "non_operating_income": 5424000,
      "operating_profit": -1151536000,
      "revenue": 0,
      "sga_expenses": 1151536000,
      "total_assets": 265858000,
      "total_equity": 81080000,
      "total_liabilities": 184778000
    },
    "2023": {
      "capital_stock": 221042000,
      "cost_of_sales": 0,
      "current_assets": 42651000,
      "current_liabilities": 54471000,
      "gross_profit": 670000000,
      "net_income": -69851000,
      "net_income_bs": -69851000,
      "non_current_assets": 42691000,
      "non_current_liabilities": 19642000,
      "non_operating_expenses": 247000,
      "non_operating_income": 2173000,
      "operating_profit": -71777000,
      "revenue": 670000000,
      "sga_expenses": 741777000,
      "total_assets": 85342000,
      "total_equity": 11229000,
      "total_liabilities": 74113000
    },
    "2024": {
      "capital_stock": 221042000,
      "cost_of_sales": 0,
      "current_assets": 35655000,
      "current_liabilities": 569699000,
      "gross_profit": 258182000,
      "net_income": -546147000,
      "net_income_bs": -546147000,
      "non_current_assets": 15126000,
      "non_current_liabilities": 16000000,
      "non_operating_expenses": 1631000,
      "non_operating_income": 21000,
      "operating_profit": -544537000,
      "revenue": 258182000,
      "sga_expenses": 802719000,
      "total_assets": 50781000,
      "total_equity": -534918000,
      "total_liabilities": 585699000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2022-06-03"
    },
    {
      "amount": "1,000,025,000",
      "changes": "1,000,025,000",
      "date": "2022-06-03"
    }
  ],
  "main_products": "실리콘 나노입자 기반 약물 전달 플랫폼",
  "phone": "02-6951-****",
  "years": [
    2024,
    2023,
    2022
  ]
}